Kindbody, a NYC-based health and technology company providing fertility, gynecology, and family-building care, raised $32m in Series B funding, bringing its total amount raised to $64m.
The round was led by Perceptive Advisors, with participation from existing investors RRE, GV (formerly Google Ventures), and Freemark Capital. New investors include major private and public healthcare funds Rock Springs Capital, Goodgrower and Claritas Capital as well as benefits consulting firm, NFP.
The funds will be used to expand Kindbody’s national footprint and build an international presence, through brick-and-mortar locations and a “Center of Excellence” (COE) network of partner clinics.
Led by Founder and CEO Gina Bartasi, Kindbody offers end-to-end services from preconception through postpartum, serving as both a provider and network solution. Their offering covers fertility treatment, including IVF and egg freezing, as well as gynecology, wellness, and LGBTQ+ services. The company leverages proprietary technology to deliver a seamless member experience and data-driven results at its 180+ Kindbody and COE locations.
The company works with employers as a full-service benefits solution and directly with patients, as an accessible provider.
The clinical team is led by Chief Medical Officer, Dr. Lynn Westphal, the former head of Stanford Medicine’s Third-Party and Fertility Preservation Program, and Founding Ob/Gyn, Dr. Fahimeh Sasan, previously at Mount Sinai. Their corporate team includes President Annbeth Eschbach, Chief Operating Officer Patty Stull, Chief Business and Legal Officer, Shilpa Patel and Chief Financial Officer, Debbie Markowitz.